Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 2 (50%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZEMAN, ROBERT A | 1 | 54.0% | +27.8% |
| LYONS, MARY M | 1 | 65.5% | +41.5% |
| LI, BAO Q | 1 | 75.9% | +26.2% |
| SKIBINSKY, ANNA | 1 | 38.8% | +29.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17642335 | Method for identifying T-cell epitopes | SKIBINSKY, ANNA | 8d overdue |
| 17786631 | Nucleic acid vaccination using neo-epitope encoding constructs | LI, BAO Q | 3d overdue |
| 18479501 | PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS | ZEMAN, ROBERT A | 12d |
| 17791038 | Vaccines targeting Neisseria gonorrhoeae | LYONS, MARY M | 28d |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1671 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18479501 | PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS | ZEMAN, ROBERT A | 1645 | §102 | Non-Final OA | 12d | Pending | Oct 02, 2023 |
| 17791038 | Vaccines targeting Neisseria gonorrhoeae | LYONS, MARY M | 1645 | §112 | Final Rejection | 28d | Pending | Jul 06, 2022 |
| 17786631 | Nucleic acid vaccination using neo-epitope encoding constructs | LI, BAO Q | 1671 | §102 | Non-Final OA | 3d overdue | Pending | Jun 17, 2022 |
| 17642335 | Method for identifying T-cell epitopes | SKIBINSKY, ANNA | 1635 | §103 | Non-Final OA | 8d overdue | Pending | Mar 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial